These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 23899656
1. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis. Skeik N, Gits CC, Ehrenwald E, Cragg AH. Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656 [Abstract] [Full Text] [Related]
2. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator. Lee K, Istl A, Dubois L, DeRose G, Forbes TL, Wiseman D, Mujoomdar A, Kribs S, Power AH. Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979 [Abstract] [Full Text] [Related]
7. Catheter-directed thrombolysis in deep venous thrombosis with use of reteplase: immediate results and complications from a pilot study. Castaneda F, Li R, Young K, Swischuk JL, Smouse B, Brady T. J Vasc Interv Radiol; 2002 Jun; 13(6):577-80. PubMed ID: 12050297 [Abstract] [Full Text] [Related]
9. Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results. Marder VJ, Comerota AJ, Shlansky-Goldberg RD, Davis JP, Deng C, Hanna K, Fineberg D. J Thromb Haemost; 2012 Jun; 10(6):985-91. PubMed ID: 22487025 [Abstract] [Full Text] [Related]
10. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions. Sugimoto K, Hofmann LV, Razavi MK, Kee ST, Sze DY, Dake MD, Semba CP. J Vasc Surg; 2003 Mar; 37(3):512-7. PubMed ID: 12618684 [Abstract] [Full Text] [Related]
11. Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis. Matosevic B, Knoflach M, Werner P, Pechlaner R, Zangerle A, Ruecker M, Kirchmayr M, Willeit J, Kiechl S. Neurology; 2013 Mar 26; 80(13):1216-24. PubMed ID: 23486872 [Abstract] [Full Text] [Related]
13. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study. Ouriel K, Katzen B, Mewissen M, Flick P, Clair DG, Benenati J, McNamara TO, Gibbens D. J Vasc Interv Radiol; 2000 Mar 26; 11(7):849-54. PubMed ID: 10928520 [Abstract] [Full Text] [Related]
15. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin. Marder VJ. Thromb Res; 2009 Mar 26; 123 Suppl 4():S56-61. PubMed ID: 19303506 [Abstract] [Full Text] [Related]
16. Low dose tissue plasminogen activator treatment for vascular thrombosis following cardiac catheterization in children: a single center experience. Bratincsák A, Moore JW, El-Said HG. Catheter Cardiovasc Interv; 2013 Nov 01; 82(5):782-5. PubMed ID: 22718305 [Abstract] [Full Text] [Related]